Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804648 · ClinicalTrials.gov registry record · Phase 4
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A Phase 4 study, sponsored by Vistakon Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00804648 is a Phase 4 study that has completed, run by Vistakon Pharmaceuticals. The registered enrollment target is 30 participants.
The verdict
NCT00804648, a Phase 4 study, has completed, sponsored by Vistakon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study compares patient symptoms and anterior segment safety in patients treated with timolol hemihydrate, generic timolol gel forming solution or timolol maleate.
Interventions
- DRUG Timolol Maleate in Sorbate
- DRUG Timolol hemihydrate
- DRUG Timolol maleate gel forming solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-11 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804648
The ClinicalTrials.gov registry entry for NCT00804648 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vistakon Pharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Timolol Maleate in Sorbate is the first listed.
NCT00804648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00804648 about?
NCT00804648 is a clinical study titled "Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension". This study compares patient symptoms and anterior segment safety in patients treated with timolol hemihydrate, generic timolol gel forming solution or timolol maleate.
What is the current status of trial NCT00804648?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2008-11. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00804648?
The interventions under investigation include: Timolol Maleate in Sorbate (DRUG), Timolol hemihydrate (DRUG), Timolol maleate gel forming solution (DRUG).
Who is sponsoring clinical trial NCT00804648?
This trial is sponsored by Vistakon Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.